2005
DOI: 10.1001/archopht.123.8.1153
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Tamoxifen-Induced Regression of a Choroidal Metastasis in a Man

Search citation statements

Order By: Relevance

Paper Sections

Select...
12
3
0
0

Citation Types

2
9
0
1

Year Published

Range
2006
2006
2024
2024

Publication Types

Select...
12
2

Relationship

0
14

Authors

Journals

citations

Cited by 14 publications

(12 citation statements)
references

References 4 publications

2
9
0
1
Order By: Relevance
How this paper cites the one you are viewing
“…Similar cases were also recently documented from Poland (Zaucha et al, 2004) and the United States (Cohen et al, 2005). Similar cases were also recently documented from Poland (Zaucha et al, 2004) and the United States (Cohen et al, 2005).…”
Section: Recent Clinical Evidence Suggests a Reappraisal Of Mpa And T
supporting
confidence: 83%
“…For many years, Japanese groups published many case reports, stating that MPA, tamoxifen and chlorinated tamoxifen analogue toremifene alone or in combination with chemotherapy induced remarkable regressions in metastatic breast cancer. Similar cases were also recently documented from Poland (Zaucha et al, 2004) and the United States (Cohen et al, 2005). Tamoxifen with cyclophosphamide, adriamycin, and UFT were applied to 20 Japanese women with metastatic breast cancer, and a 58% response rate was observed, which was accompanied with a 73% decrease of soft tissue-and a 50% decrease of liver metastases (Yamaguchi et al, 1999).…”
Section: Recent Clinical Evidence Suggests a Reappraisal Of Mpa And T
supporting
confidence: 58%
See 1 more Smart Citation